182 related articles for article (PubMed ID: 326171)
1. The effect of hypolipidemic drugs on plasma lipoproteins.
Levy RI
Annu Rev Pharmacol Toxicol; 1977; 17():499-510. PubMed ID: 326171
[No Abstract] [Full Text] [Related]
2. Results of treatment of hyperlipidemias: long-term compliance and effect of lipid metabolism.
Frantz ID
Adv Exp Med Biol; 1977; 82():649-55. PubMed ID: 920422
[No Abstract] [Full Text] [Related]
3. Hypolipidemic drugs.
Fleischmajer R
Am Fam Physician; 1978 Feb; 17(2):188-90. PubMed ID: 622945
[No Abstract] [Full Text] [Related]
4. The mechanism of action of lipid-lowering drugs.
LaRosa JC
Angiology; 1982 Sep; 33(9):562-76. PubMed ID: 7125296
[TBL] [Abstract][Full Text] [Related]
5. Drug therapy of hyperlipoproteinemia.
Levy RI
JAMA; 1976 May; 235(21):2334-6. PubMed ID: 946632
[No Abstract] [Full Text] [Related]
6. [Lipid-lowering drugs. Therapeutics and adverse effects].
Vogelberg KH
Med Klin; 1979 Aug; 74(32-33):1171-8. PubMed ID: 224293
[No Abstract] [Full Text] [Related]
7. Arterial cholesterol esterase.
Kritchevsky D
Adv Exp Med Biol; 1977; 82():878-81. PubMed ID: 920445
[No Abstract] [Full Text] [Related]
8. Drug treatment of hyperlipidemia.
Yeshurun D; Gotto AM
Am J Med; 1976 Mar; 60(3):379-96. PubMed ID: 1258886
[TBL] [Abstract][Full Text] [Related]
9. [Drug treatment of primary hyperlipoproteinemia (author's transl)].
Klose G; Mordasini R; Middelhoff G; Augustin J; Greten H
Klin Wochenschr; 1978 Feb; 56(3):99-110. PubMed ID: 628199
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hyperlipidemia.
Levy RI; Morganroth J; Rifkind BM
N Engl J Med; 1974 Jun; 290(23):1295-301. PubMed ID: 4363888
[No Abstract] [Full Text] [Related]
11. Hypolipidemic drugs.
Sirtori C; Fumagalli R; Paoletti R
Adv Exp Med Biol; 1973; 38():171-98. PubMed ID: 4594063
[No Abstract] [Full Text] [Related]
12. [Hypolipemic agents].
Paoletti R; Fumagalli R; Sirtori R
Minerva Med; 1973 Apr; 64(24):1267-75. PubMed ID: 4707410
[No Abstract] [Full Text] [Related]
13. [Hypolipidaemic agents (author's transl)].
Tillement JP; Albengres E; Choisy H; Millart H
Nouv Presse Med; 1980 Oct; 9(40):2947-50. PubMed ID: 7443428
[TBL] [Abstract][Full Text] [Related]
14. [Antilipemic agents available after the ban on clofibrate: clinical-pharmacological view].
Mertz DP
Fortschr Med; 1979 Apr; 97(15):695-6, 698. PubMed ID: 456970
[TBL] [Abstract][Full Text] [Related]
15. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
Orö L; Olsson AG; Rössner S; Carlson LA
Postgrad Med J; 1975; 51(8):suppl 76-81. PubMed ID: 215986
[TBL] [Abstract][Full Text] [Related]
16. Therapy of the hyperlipoproteinemias.
Bagdade JD
Acta Diabetol Lat; 1972 Dec; 9 Suppl 2():98-110. PubMed ID: 4605376
[No Abstract] [Full Text] [Related]
17. [Therapeutic orientation in the hyperlipidemias].
Forti N; Diament J; Giannini SD
Arq Bras Cardiol; 1979 Sep; 33(3):207-15. PubMed ID: 396911
[No Abstract] [Full Text] [Related]
18. Treatment of type II and type IV Fredrickson's hyperlipoproteinemia.
Crepaldi G; Fellin R; Briani G
Adv Exp Med Biol; 1973; 38():199-217. PubMed ID: 4766527
[No Abstract] [Full Text] [Related]
19. Therapy of hyperlipidemic states.
Havel RJ; Kane JP
Annu Rev Med; 1982; 33():417-33. PubMed ID: 7044276
[No Abstract] [Full Text] [Related]
20. Pharmacological modification of lipoprotein metabolism.
Shepherd J; Packard CJ
Biochem Soc Trans; 1987 Apr; 15(2):199-201. PubMed ID: 3556260
[No Abstract] [Full Text] [Related]
[Next] [New Search]
